Lv4
448 积分 2026-07-25 加入
Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future
20天前
已完结
Dual PI3K/mTOR inhibition is required to combat resistance to CDK4/6 inhibitor and endocrine therapy in PIK3CA -mutant breast cancer
20天前
已完结
NP-ALT, a Liposomal:Peptide Drug, Blocks p27Kip1 Phosphorylation to Induce Oxidative Stress, Necroptosis, and Regression in Therapy-Resistant Breast Cancer Cells
20天前
已完结
Single-cell transcriptomics reveals immune landscape dynamics in metastatic hormone receptor-positive breast cancer treated with abemaciclib and endocrine therapy
20天前
已完结
Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer
21天前
已完结
Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer
21天前
已完结
Oral antimicrobial peptide-EGCG nanomedicines for synergistic treatment of ulcerative colitis
29天前
已完结
Orchestrating Gut Disorders by Oral Delivery of a Living–Synthetic Hybrid Hydrogel
29天前
已完结
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial
1个月前
已完结
Organoid Medicine for Inflammatory Bowel Disease
1个月前
已完结
皖公网安备34019202002308
